[Modern genetic counselling : Practical aspects exemplified by hypertrophic cardiomyopathy]

F Czepluch1, G Hasenfuß2, B Wollnik3

  • 1Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Robert-Koch-Str. 40, 37075, Göttingen, Deutschland. f.czepluch@med.uni-goettingen.de.

Der Internist
|June 27, 2018
PubMed

Insights

Genetic counseling and molecular testing are crucial for diagnosing inherited heart conditions like hypertrophic cardiomyopathy (HCM). Early diagnosis aids treatment and prognosis for patients and families.

Area of Science:

  • Cardiology
  • Genetics
  • Medical Diagnostics

Background:

  • Inherited monogenic heart diseases require genetic counseling and molecular testing.
  • Early diagnosis through molecular diagnostics is vital for patient and family management.
  • Hypertrophic cardiomyopathy (HCM) is the most common monogenic structural heart disease.

Purpose of the Study:

  • To elucidate essential aspects of modern genetic counseling for inherited heart diseases.
  • To illustrate the application of genetic counseling and diagnostics using HCM case examples.
  • To highlight the importance of genetic diagnostics for early detection, therapy, and prognosis.

Main Methods:

  • Review of genetic counseling principles in monogenic heart diseases.
  • Case study analysis of hypertrophic obstructive cardiomyopathy.
  • Case study analysis of congenital HCM associated with Noonan syndrome.

Main Results:

  • Genetic counseling and molecular testing are fundamental for suspected inherited monogenic heart diseases.
  • Molecular diagnostics facilitate early diagnosis, preventive therapy, and prognosis assessment.
  • HCM serves as a key example to demonstrate the utility of genetic approaches.

Conclusions:

  • Genetic counseling and molecular diagnostics are indispensable for managing inherited monogenic heart diseases.
  • Personalized management strategies are informed by genetic testing results.
  • Understanding genetic underpinnings of heart conditions improves patient outcomes and family screening.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
509
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
575
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
575
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
700
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
462
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
613